Table 2.

CMR Imaging Results

Variable	All Patients (n=1082)	MACE (n=73)	No MACE (n=1007)	P Value
Infarct size (% LV)*	13.3 (5.4–21.7)	20.4 (9.3–28.9)	13.1 (5.3–21.3)	0.001
Microvascular obstruction (% LV)*	0.4 (0–2.0)	1.1 (0–3.2)	0.3 (0–1.9)	0.029
LVEF (%)	50.5 (43.5–57.6)	40.0 (33.0–51.9)	50.9 (44.3–57.6)	<0.001
LV end‐diastolic volume, mL	143 (116–171)	145 (122–170)	143 (116–171)	0.820
LV end‐systolic volume, mL	70 (53–91)	86 (61–110)	69 (53–89)	0.001
CURE	0.84 (0.75–0.89)	0.76 (0.67–0.86)	0.84 (0.76–0.89)	<0.001
RURE	0.75 (0.67–0.83)	0.69 (0.60–0.79)	0.76 (0.67–0.83)	<0.001

Data presented as median (interquartile range). P values were calculated for comparison of patients with and without MACE. CMR indicates cardiac magnetic resonance; CURE, circumferential uniformity ratio estimate; LV, left ventricular; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac events; % LV, percentage of left ventricular mass; RURE, radial uniformity ratio estimate. Two patients were lost to follow‐up regarding MACE.

^*Late gadolinium enhancement imaging was available for 1055 patients (MACE, n=68; no MACE, n=985).